1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. PROSTHETIC HEART VALVE MARKET BY TYPE
5.1. Introduction
5.2. Mechanical Heart Valve
5.3. Tissue Heart Valve
6. PROSTHETIC HEART VALVE MARKET BY END-USER
6.1. Introduction
6.2. Hospitals and Clinics
6.3. Research Laboratories
6.4. Others
7. PROSTHETIC HEART VALVE MARKET BY PROCEDURE TYPE
7.1. Introduction
7.2. Surgical Valve Replacement
7.3. Transcatheter Valve Replacement
8. PROSTHETIC HEART VALVE MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Taiwan
8.6.6. Thailand
8.6.7. Indonesia
8.6.8. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Boston Scientific Corporation
10.2. Edwards Lifesciences Corporation
10.3. Abbott
10.4. Medtronic
10.5. JenaValve Technology Inc.
10.6. Corcym S.r.l. (LivaNova PLC)
10.7. CryoLife Inc
10.8. Meril Life Sciences Pvt. Ltd.
10.9. Lepu Medical Technology Co., Ltd
10.10. TTK Healthcare Limited
10.11. Symetis SA
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES